Skin punch biopsies were performed on PD patients diagnosed with the LRRK2 G2019S mutation and on control subjects with no known PD-related mutations or any other neurological disorder; additional mutant fibroblasts were purchased from Coriell (ND29370; Coriell Institute). This evidence concerns the gene LRRK2 and Parkinson disease.